The stocks on the Combinatorial Chemistry Leaders List offer drug maker's powerful tools used to develop new drugs. Using High Throughput Screening, computational analysis and anti-sense techniques the companies on the Combinatorial Chemistry Leaders List help drug makers and Biotech Companies create broad libraries of millions of potentially therapeutic compounds while reducing the risk of drug discovery and lowering the cost to the individual Drug Maker Companies. This is very important because the average cost to develop and commercialize a new drug is $500 million. One of the reasons the cost is so high is that only one in ten potential drugs survives the average of ten to fourteen years within the convoluted and costly clinical trial system designed to bring it safely to market. The companies on this list speed that process while making it less expensive and more predictable.

The Combinatorial Chemistry Leaders Stock List

ARQL ISIS

ARQL through ISIS

Let me see a chart at Big Charts

Let me search for more news
SEARCH YAHOO NEWS